To that aim and following studies on the expression in normal murine and bovine ovaries (13,14), we provide novel data regarding the expression of both asprosin and its cognate receptor, OR4M1, in normal human ovaries and ovarian cancer. This evidence concerns the gene FBN1 and ovarian cancer.